-

GE Healthcare Unveils Latest Ultra-Premium Ultrasound in Women’s Health Portfolio

  • Voluson Expert 22 represents a major step forward in ultrasound innovation from a market leader in Women’s Health Ultrasound
  • Next-generation architecture behind Voluson Expert 22 includes Voluson graphic-based beam former technology; AI powered tools; and customizable touch panel, color and lighting options

CHICAGO--(BUSINESS WIRE)--GE Healthcare today unveiled its most advanced ultrasound yet, the next-generation Voluson™ Expert 22. This latest addition to GE Healthcare’s award-winning Women’s Health portfolio utilizes graphic-based beam former technology, which produces higher quality images and offers greater flexibility in imaging functions. Cutting-edge tools powered by Artificial Intelligence (AI) ensure greater consistency in exams and decreased number of tasks. Customizable touch panels, color and lighting options provide for a revolutionary user experience.

As pregnancies grow increasingly complex, clinicians are demanding improvements in technology that allow for greater confidence at the point of care. Shrinking workforces are straining healthcare systems around the world, and without intensive training to operate complex medical imaging technology, clinicians are therefore demanding smart, intuitive systems that reduce the burden on individual users.

The Voluson Expert 22’s Lyric Architecture unlocks new imaging and processing power to achieve higher resolution, detailed images—and increased independence from body habitus and other difficult scanning conditions. The Lyric Architecture generates new levels of penetration, resolution, and frame rates to reveal fine anatomy in 2D/3D/4D with ease, and delivers uniformity throughout the image with increased spatial and contrast resolution.

According to Prof. Dr. Rabih Chaoui, Managing Director at the Center for Prenatal Diagnosis and Human Genetics in Berlin, Germany, said: “The Voluson Expert 22 is a masterpiece of engineering with exceptional 2D images from thin to difficult scanning patients. This machine also has the outstanding ergonomics and is the most customizable system ever produced. It is one of the best ultrasound machines I have ever used.”1

Voluson’s modern user interface is simple and seamless, and the 23.8 inch high-definition ultrasound (HDU) display offers 3 image sizes including unique full screen images that allows clinicians to work comfortably and see finer details with ease. Clinicians can personalize the user interface according to their unique preferences and Respond probe activation automatically initializes the probes and presets when removed from the probe holder.

Dr. Lawrence Platt, MD, an Obstetrician-gynecologist at the Center for Fetal Medicine in Los Angeles, USA, commented: “By using AI, we are pushing limits and enhancing diagnostic capabilities. At the same time, the functionality makes exams easier. The AI built into this machine is so far advanced compared to what we've seen before, and it’s only a hint. It's our responsibility to push it even further by using it, by challenging it, and showing it, makes a difference.”1

AI-powered tools include SonoLyst, which helps identify fetal anatomy seen on standard views while enhancing efficiency by up to 65%* by adding annotations and measurements; SonoPelvicFloor, which simplifies the exam process by 80%* automating plane alignment and measurements while offering workflow guidance to improve efficiency while eliminating uncertainty; SonoCNS which supports consistent measurements and help drive workflow efficiency and reduce exam time by 81%* by helping align and display recommended views and measurements of the fetal brain from a 3D Volume.

“Technology continues to move obstetrics and gynecology forward, but there is a delicate balance between using technology to enhance medical care and the human role in medicine” said, Gerald Seifriedsberger, General Manager- Women’s Health. “We are incredibly proud to build on our legacy of innovation in women’s health with the introduction of the Voluson Expert 22, and deliver advanced ultrasound imaging at the point of care that allows for more shared decision-making between clinician and patient.

Designed in partnership with leading OBGYN’s, the intuitive and customizable ultra-premium Voluson Expert 22 is designed for a world where patients want answers earlier, and clinicians need to answer questions with greater confidence.

With GE Healthcare’s Voluson ultrasound systems, clinicians conduct more than 400 million women’s health ultrasound exams every year.

For more information on GE Healthcare’s Voluson Expert 22, visit https://www.gehealthcare.com/products/ultrasound/voluson/voluson-Expert22.

GE Healthcare is the $17.7 billion healthcare business of GE (NYSE: GE). As a leading global medical technology, pharmaceutical diagnostics and digital solutions innovator, GE Healthcare enables clinicians to make faster, more informed decisions through intelligent devices, data analytics, applications and services, supported by its Edison intelligence platform. With over 100 years of healthcare industry experience and around 47,000 employees globally, the company operates at the center of an ecosystem working toward precision health, digitizing healthcare, helping drive productivity and improve outcomes for patients, providers, health systems and researchers around the world.

Follow us on Facebook, LinkedIn, Twitter, Instagram and Insights for the latest news, or visit our website www.gehealthcare.com for more information.

______________________________
1 Statements by GE’s customers are based on their own opinions and on results achieved in the customer’s unique setting. Since there is no ‘typical’ clinical setting and many variables exist (e.g. hospital size, case mix), there can be no guarantee that the customers will achieve the same results. GE Healthcare may have unrelated contractual agreement with Dr. Chaoui and/or Dr. Platt

Contacts

Nader Abou-Guendia
Nader.abou-guendia@ge.com
+97155 980 4206

GE Healthcare

NYSE:GE

Release Versions

Contacts

Nader Abou-Guendia
Nader.abou-guendia@ge.com
+97155 980 4206

More News From GE Healthcare

GE HealthCare expands mammography collaboration with RadNet’s DeepHealth subsidiary to extend global access to DeepHealth’s AI-powered breast cancer screening solutions

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced an expanded collaboration with DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (Nasdaq: RDNT), to further the innovation, commercialization, and adoption of advanced AI-powered mammography tools. The announcement coincides with the Society of Breast Imaging (SBI) Annual Symposium, where GE HealthCare will showcase its latest advancements in breast imaging and w...

GE HealthCare announces digital integration between bkActiv™ intraoperative ultrasound system and Medtronic Stealth AXiS™ surgical navigation system

CHICAGO--(BUSINESS WIRE)--GE HealthCare today announced a digital integration between the GE HealthCare bkActiv™ intraoperative ultrasound (iUS) system and the Medtronic Stealth AXiS™ surgical navigation system, which is now commercially available to provide real-time advanced imaging during cranial procedures to complement surgical planning and navigation workflows. This integration builds on an existing strategic alliance between the companies to accelerate next-generation technology innovati...

GE HealthCare to announce first quarter 2026 results on April 29, 2026

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) will announce its first quarter 2026 financial results before the market opens on Wednesday, April 29, 2026. The GE HealthCare management team will also host a conference call and webcast at 8:30 a.m. Eastern Time / 7:30 a.m. Central Time on that same day, which will be a live webcast and accessible at https://investor.gehealthcare.com/news-events/events. The earnings release, accompanying financial information, and webcast replay also will...
Back to Newsroom